ChemicalBook--->CAS DataBase List--->132928-46-2

132928-46-2

132928-46-2 Structure

132928-46-2 Structure
IdentificationBack Directory
[Name]

PF 10040
[CAS]

132928-46-2
[Synonyms]

PF 10040
[Molecular Formula]

C20H24ClNO2
[MDL Number]

MFCD00908204
[MOL File]

132928-46-2.mol
[Molecular Weight]

345.87
Hazard InformationBack Directory
[Description]

PF 10040 is a platelet activating factor (PAF) antagonist.
[Uses]

PF-10040 is a quinoline derivative that can inhibit PAF-induced airway hyperresponsiveness. PF-10040 also shows protective effect in experimental NSAID-gastritis[1][2].
[References]

[1] Herd CM, et, al. Effect of PF 10040 on PAF-induced airway responses in neonatally immunized rabbits. Br J Pharmacol. 1994 Jan;111(1):7-12. DOI:10.1111/j.1476-5381.1994.tb14016.x
[2] Wallace JL, et, al. Protective effects of PF-10040 in experimental NSAID-gastritis: role of leukocytes, leukotrienes and PAF. J Lipid Mediat. 1993 Jun;7(2):183-96. PMID:8400119
132928-46-2 suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354; +17819995354 , +17819995354
Website: https://www.targetmol.com/
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354 , +17819995354
Website:
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Company Name: CHEMICAL LAND21  
Tel: 82- 2 -783 - 8063
Website: www.chemicalland21.com
Tags:132928-46-2 Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.